
Bristol-Myers Squibb Company BMY
$ 60.74
-2.55%
Annual report 2025
added 02-11-2026
Bristol-Myers Squibb Company P/S Ratio 2011-2026 | BMY
Annual P/S Ratio Bristol-Myers Squibb Company
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2.54 | 2.36 | 2.23 | 3.35 | 3.26 | 3.13 | 5.5 | 3.54 | 5.06 | 4.19 | 6.26 | 6.29 | 5.07 | 3.47 | 2.58 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 6.29 | 2.23 | 3.92 |
P/S Ratio of other stocks in the Biotechnology industry
| Issuer | P/S Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
MorphoSys AG
MOR
|
1.75 | - | 2.43 % | $ 254 M | ||
|
Acer Therapeutics
ACER
|
25.8 | - | 2.71 % | $ 14 M | ||
|
Acorda Therapeutics
ACOR
|
0.142 | - | -24.86 % | $ 820 K | ||
|
ADMA Biologics
ADMA
|
7.41 | $ 15.57 | -5.89 % | $ 3.71 B | ||
|
AgeX Therapeutics
AGE
|
0.099 | - | -10.17 % | $ 12.2 K | ||
|
Aeglea BioTherapeutics
AGLE
|
489 | - | - | $ 1.01 B | ||
|
Applied Genetic Technologies Corporation
AGTC
|
65.5 | - | - | $ 26.5 M | ||
|
AbCellera Biologics
ABCL
|
12.8 | $ 3.58 | -1.38 % | $ 1.07 B | ||
|
I-Mab
IMAB
|
94.1 | - | - | $ 866 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
5.53 | - | - | $ 40.3 B | ||
|
Anika Therapeutics
ANIK
|
2.24 | $ 14.19 | -1.18 % | $ 208 M | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
2.39 K | - | -1.52 % | $ 24.7 M | ||
|
Midatech Pharma plc
MTP
|
137 | - | -18.52 % | $ 27.3 M | ||
|
Aptorum Group Limited
APM
|
105 | $ 0.82 | -0.73 % | $ 4.47 M | ||
|
Alpine Immune Sciences
ALPN
|
8.94 | - | - | $ 2.17 B | ||
|
Apellis Pharmaceuticals
APLS
|
2.76 | $ 20.24 | 1.91 % | $ 2.55 B | ||
|
Ampio Pharmaceuticals
AMPE
|
106 | - | -11.43 % | $ 502 K | ||
|
ANI Pharmaceuticals
ANIP
|
1.95 | $ 75.6 | -1.22 % | $ 1.46 B | ||
|
Applied Therapeutics
APLT
|
54.1 | - | - | $ 8.42 M | ||
|
Autolus Therapeutics plc
AUTL
|
1.37 K | $ 1.5 | -8.28 % | $ 383 M | ||
|
Aravive
ARAV
|
6.61 | - | -13.39 % | $ 1.45 M | ||
|
Adverum Biotechnologies
ADVM
|
76.4 | - | - | $ 86.2 M | ||
|
Институт стволовых клеток человека
ISKJ
|
2.61 | - | - | - | ||
|
Athersys
ATHX
|
253 | - | 3.77 % | $ 22.4 M | ||
|
AVEO Pharmaceuticals
AVEO
|
2.32 | - | - | $ 521 M | ||
|
Axsome Therapeutics
AXSM
|
13.6 | $ 159.87 | -2.57 % | $ 7.95 B | ||
|
BridgeBio Pharma
BBIO
|
26.1 | $ 65.73 | -1.22 % | $ 12.6 B | ||
|
BioDelivery Sciences International
BDSI
|
1.85 | - | -4.8 % | $ 255 M | ||
|
Acasti Pharma
ACST
|
0.203 | - | 4.01 % | $ 150 M | ||
|
BeiGene, Ltd.
BGNE
|
66.4 | - | 0.49 % | $ 251 B | ||
|
Bellicum Pharmaceuticals
BLCM
|
5.55 | - | -9.72 % | $ 5.89 M | ||
|
Berkeley Lights
BLI
|
1.49 | - | -7.31 % | $ 87 M | ||
|
Equillium
EQ
|
2.35 | $ 1.79 | 2.29 % | $ 62.2 M | ||
|
CureVac N.V.
CVAC
|
281 | - | - | $ 867 M | ||
|
Aeterna Zentaris
AEZS
|
7.87 | - | 5.93 % | $ 314 M | ||
|
BioMarin Pharmaceutical
BMRN
|
3.63 | $ 60.54 | 0.18 % | $ 11.6 B | ||
|
Burford Capital Limited
BUR
|
6.35 | $ 8.26 | -1.31 % | $ 1.36 B | ||
|
Cabaletta Bio
CABA
|
50.3 M | $ 3.2 | -6.71 % | $ 3.74 M | ||
|
AIkido Pharma
AIKI
|
1.08 | - | 1.93 % | $ 17.4 M | ||
|
Agenus
AGEN
|
0.00137 | $ 2.93 | -8.44 % | $ 1.05 M | ||
|
Ayala Pharmaceuticals
AYLA
|
11.2 | - | - | $ 7.46 M | ||
|
Capricor Therapeutics
CAPR
|
6.17 | $ 25.74 | 0.94 % | $ 689 M |